Russell Investments Group, Ltd.

Position in OMER — Omeros Corp

CIK 1692234 Seattle, WA

Position in OMER

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$287,981

+$140,163 QoQ

Shares Held

30,282

+116.3% QoQ

Ownership

0.042%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#80

of 172 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 90% Shared 0% None 10%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. OMER ranks #172 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$287,981	30,282	+116.3%	Shares	Defined	2026-08-06
2026-03-31	$147,818	13,998	-0.1%	Shares	Defined	2026-05-08
2025-12-31	$240,760	14,014	+31.0%	Shares	Defined	2026-02-17
2025-09-30	$43,848	10,695	+113.1%	Shares	Defined	2025-11-13
2025-06-30	$15,054	5,018	+434.4%	Shares	Defined	2025-08-13
2025-03-31	$7,718	939	-13.9%	Shares	Defined	2025-05-13
2024-12-31	$10,779	1,091	+617.8%	Shares	Defined	2025-02-13
2024-09-30	$603	152	-92.3%	Shares	Defined	2024-11-13
2024-06-30	$8,018	1,975	-89.6%	Shares	Defined	2024-08-08
2020-12-31	$272,653	19,080	-24.9%	Shares	Sole	2021-02-08
2020-09-30	$256,773	25,398	+746.6%	Shares	Sole	2020-11-09
2020-03-31	$40,110	3,000	—	Shares	Sole	2020-05-06
No filing history on record for this holder in this stock.